男人女人午夜视频免费,免费人妻无码不卡中文字幕系,国产A级三级三级三级,成年无码aⅴ片在线观看

補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)

Multiplex Assay Kit for Complement Component 5a (C5a) ,etc. by FLIA (Flow Luminescence Immunoassay)

(注:?jiǎn)未位鞙y(cè)多因子不超過8個(gè)指標(biāo) )

  • 補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)產(chǎn)品包裝(模擬)
  • 補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)產(chǎn)品包裝(模擬)
  • Certificate通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

本試劑盒用于檢測(cè)補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法),經(jīng)檢測(cè)與其它相似物質(zhì)無明顯交叉反應(yīng)。
由于受到技術(shù)及樣本來源的限制,不可能完成對(duì)所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測(cè),因此本試劑盒有可能與未經(jīng)檢測(cè)的其它物質(zhì)有交叉反應(yīng)。

回收率

分別于定值血清及血漿樣本中加入一定量的補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)(加標(biāo)樣品),重復(fù)測(cè)定并計(jì)算其均值,回收率為測(cè)定值與理論值的比率。

樣本回收率范圍(%)平均回收率(%)
serum(n=5)84-9288
EDTA plasma(n=5)80-8983
heparin plasma(n=5)80-9889
sodium citrate plasma(n=5)81-9687

精密度

精密度用樣品測(cè)定值的變異系數(shù)CV表示。CV(%) = SD/mean×100
批內(nèi)差:取同批次試劑盒對(duì)低、中、高值定值樣本進(jìn)行定量檢測(cè),每份樣本連續(xù)測(cè)定20 次,分別計(jì)算不同濃度樣本的平均值及SD值。
批間差:選取3個(gè)不同批次的試劑盒分別對(duì)低、中、高值定值樣本進(jìn)行定量測(cè)定,每個(gè)樣本使用同一試劑盒重復(fù)測(cè)定8次,分別計(jì)算不同濃度樣本的平均值及SD值。
批內(nèi)差: CV<10%
批間差: CV<12%

線性

在定值血清及血漿樣本內(nèi)加入適量的補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法),并倍比稀釋成1:2,1:4,1:8,1:16的待測(cè)樣本,線性范圍即為稀釋后樣本中補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)含量的測(cè)定值與理論值的比率。

樣本1:21:41:81:16
serum(n=5)80-91%88-104%94-101%83-98%
EDTA plasma(n=5)95-105%80-102%95-105%85-95%
heparin plasma(n=5)88-95%79-91%98-105%93-103%
sodium citrate plasma(n=5)99-105%81-95%86-93%89-98%

穩(wěn)定性

經(jīng)測(cè)定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
為減小外部因素對(duì)試劑盒破壞前后檢測(cè)值的影響,實(shí)驗(yàn)室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗(yàn)室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗(yàn)員來進(jìn)行操作可減少人為誤差。

實(shí)驗(yàn)流程

1. 實(shí)驗(yàn)前標(biāo)準(zhǔn)品、試劑及樣本準(zhǔn)備;
2. 加樣(標(biāo)準(zhǔn)品、樣本、磁珠)標(biāo)準(zhǔn)品或樣本100μL及磁珠10μL,
    37°C酶標(biāo)板振蕩器孵育90分鐘;
3. 磁吸甩干,加檢測(cè)溶液A100μL,37°C酶標(biāo)板振蕩器孵育60分鐘;
4. 磁吸洗板3次;
5. 加檢測(cè)溶液B100μL,37°C振動(dòng)孵育30分鐘;
6. 磁吸洗板3次;
7. 加鞘液100μL,旋渦震蕩2分鐘后讀數(shù)。

實(shí)驗(yàn)原理

將補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)抗體包被于磁珠,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本以及磁珠,其中的補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)抗體,將未結(jié)合的生物素化抗體洗凈后,加入PE標(biāo)記的親和素,再次徹底洗滌后即可上機(jī)讀數(shù)。MFI值和樣品中的補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)呈正相關(guān)。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào)適用物種:Canis familiaris; Canine (Dog,犬)應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPA388Ca01補(bǔ)體成分5a(C5a)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
CPA388Ca21補(bǔ)體成分5a(C5a)卵白蛋白偶聯(lián)物Immunogen; SDS-PAGE; WB.
SPA388Ca01補(bǔ)體成分5a(C5a)合成多肽Immunogen; Blocking Peptide.
PAA388Ca08補(bǔ)體成分5a(C5a)多克隆抗體WB; IHC; ICC; IP.
SEA388Ca補(bǔ)體成分5a(C5a)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMA388Ca補(bǔ)體成分5a(C5a)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志參考文獻(xiàn)
Molecular ImmunologyCathepsin D is released after severe tissue trauma in vivo and is capable of generating C5a in vitro[ScienceDirect: S0161589011008297]
Journal of Reproductive ImmunologyElevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia[PubMed: 23415845]
The Journal of Clinical Investigation Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis[PubMed: PMC3195471]
Journal of Antimicrobial ChemotherapyEfficacy of a synthetic antimicrobial peptidomimetic versus vancomycin in a Staphylococcus epidermidis device-related murine peritonitis model[Pubmed: 23645587]
Journal of Orthopaedic ResearchConversion from external fixator to intramedullary nail causes a second hit and impairs fracture healing in a severe trauma model[Pubmed: 23070742]
SpringerPlusTherapeutic effects of sesame oil on monosodium urate crystal-induced acute inflammatory response in rats[Pubmed: 24353977]
American Journal fo Reproductive ImmunologyEvaluation of the Markers of Inflammation in the Umbilical Cord Blood of Newborns of Mothers with Thrombophilia[Pubmed:25209155]
Gynecol Obstet InvestComplement Split Products C3a/C5a and Receptors: Are They Regulated by Circulating Angiotensin II Type 1 Receptor Autoantibody in Severe Preeclampsia?[PubMed: 26485247]
Journal of NeuroimmunologyAcute and prolonged complement activation in the central nervous system during herpes simplex encephalitis[Pubmed:27235358]
International ImmunopharmacologyConsistency and pathophysiological characterization of a rat polymicrobial sepsis model via the improved cecal ligation and puncture surgery[Pubmed:26802602]
Digital RepositoryDosagem de fra??es ativadas do sistema complemento em empiema induzido em ratos[10183]
Environmental PollutionCadmium-induced immune abnormality is a key pathogenic event in human and rat models of preeclampsia[pubmed:27511439]
Cancer LettersComplement C5a/C5aR pathway potentiates the pathogenesis Q5 of gastric cancer by down-regulating p21 expression[pubmed:29031586]
Acta PaediatricaSerum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children[DOI:?10.1111/apa.14106]
Scientific ReportsSplenectomy modulates early immuno-inflammatory responses to trauma-hemorrhage and protects mice against secondary sepsis[Pubmed: 30291296]
NutrientsThe Beneficial Effects of Lactobacillus plantarum PS128 on High-Intensity, Exercise-Induced Oxidative Stress, Inflammation, and Performance in Triathletes[Pubmed: 30736479]
Journal of?NeuroVirologyIntrathecal complement activation by the classical pathway in tick-borne encephalitis[Pubmed: 30850976]
PLoS OneSepsis causes right ventricular myocardial inflammation independent of pulmonary hypertension in a porcine sepsis model[Pubmed: 31247004]
Frontiers in ImmunologyC5a/C5aR Pathway is Critical for the Pathogenesis of Psoriasis[Pubmed: 31447855]
PhytomedicineNovel evidence that an alternative complement cascade pathway is involved in optimal mobilization of hematopoietic stem/progenitor cells in Nlrp3?…[]
AgingC5aR deficiency attenuates the breast cancer development via the p38/p21 axis[Pubmed: 32669478]
STEM CELL REVIEWS AND REPORTSA Novel Evidence That Mannan Binding Lectin (MBL) Pathway of Complement Cascade Activation is Involved in Homing and Engraftment of Hematopoietic Stem …[Pubmed: 32406006]
Modulation of C5a-C5aR interactions against murine mammary cancer cell line[]
FASEB JC‐reactive protein inhibits C3a/C3aR‐dependent podocyte autophagy in favor of diabetic kidney disease[Pubmed:35503088]